Cardiol Therapeutics reported earnings of -$ 0.08 per CRDL share on Nov 12, 2026, beating analysts' expectations by
| Report Date | Nov 12, 2026 |
|---|---|
| Forecasted EPS | -$ 0.06 |
| Earnings Per Share (Surprise) | -$ 0.08 (-$ 0.02) |
| Last Year's EPS | -$ 0.08 |
| EPS YoY Change |
Out of the last 44 earnings reporting periods, Cardiol Therapeutics beat analysts’ expectations 18 times and fell short of expectations 5 time(s). Cardiol Therapeutics reported earnings per share of -$ 0.08 in the last report falling to reach an estimated EPS of -$ 0.06 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 12, 2026 | -$ 0.06 | -$ 0.08 | -$ 0.09 | |
| Aug 13, 2026 | -$ 0.09 | -$ 0.04 | -$ 0.07 | |
| May 11, 2026 | -$ 0.07 | -$ 0.07 | -$ 0.07 | |
| Mar 30, 2026 | -$ 0.09 | -$ 0.05 | -$ 0.10 | |
| Nov 13, 2025 | -$ 0.09 | -$ 0.09 | -$ 0.07 | |
| Aug 14, 2025 | -$ 0.11 | -$ 0.07 | -$ 0.13 | |
| May 14, 2025 | -$ 0.09 | -$ 0.07 | -$ 0.07 | |
| May 13, 2025 | -$ 0.13 | -$ 0.10 | -$ 0.10 | |
| Mar 31, 2025 | -$ 0.08 | -$ 0.07 | -$ 0.09 | |
| Nov 14, 2024 | -$ 0.10 | -$ 0.13 | -$ 0.09 | |
| Aug 12, 2024 | -$ 0.10 | -$ 0.07 | -$ 0.07 | |
| May 14, 2024 | -$ 0.06 | -$ 0.10 | -$ 0.09 | |
| Apr 1, 2024 | -$ 0.09 | -$ 0.09 | -$ 0.09 | |
| Mar 26, 2024 | -$ 0.09 | -$ 0.09 | -$ 0.08 | |
| Nov 14, 2023 | -$ 0.09 | -$ 0.07 | -$ 0.09 | |
| Aug 11, 2023 | -$ 0.09 | -$ 0.09 | -$ 0.09 | |
| Aug 10, 2023 | -$ 0.12 | -$ 0.09 | -$ 0.10 | |
| May 15, 2023 | -$ 0.08 | -$ 0.08 | -$ 0.10 | |
| Mar 28, 2023 | $ 0.15 | -$ 0.09 | -$ 0.11 | |
| Mar 27, 2023 | -$ 0.06 | -$ 0.09 | -$ 0.09 |
Cardiol Therapeutics’s stock was trading at $ 1.01 on Nov 11, 2026 a day before the last earnings report was released.Following the release of the earnings report, CRDL’s price decreased to $ 1.00 on Nov 13, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 12, 2026 | -$ 0.08 | $ 1.01 | $ 1.00 | |
| Aug 13, 2026 | -$ 0.04 | $ 1.52 | $ 1.80 | |
| May 11, 2026 | -$ 0.07 | $ 1.32 | $ 1.35 | |
| Mar 30, 2026 | -$ 0.05 | $ 1.25 | $ 1.35 | |
| Nov 13, 2025 | -$ 0.09 | $ 1.04 | $ 1.02 | |
| Aug 14, 2025 | -$ 0.07 | $ 1.11 | $ 1.31 | |
| May 14, 2025 | -$ 0.07 | $ 1.15 | $ 1.14 | |
| May 13, 2025 | -$ 0.10 | $ 1.13 | $ 1.11 | |
| Mar 31, 2025 | -$ 0.07 | $ 0.96 | $ 0.9276 | |
| Nov 14, 2024 | -$ 0.13 | $ 1.91 | $ 1.82 | |
| Aug 12, 2024 | -$ 0.07 | $ 2.01 | $ 2.10 | |
| May 14, 2024 | -$ 0.10 | $ 2.18 | $ 2.32 | |
| Apr 1, 2024 | -$ 0.09 | $ 1.81 | $ 1.81 | |
| Mar 26, 2024 | -$ 0.09 | $ 1.46 | $ 1.80 | |
| Nov 14, 2023 | -$ 0.07 | $ 0.765 | $ 0.84 | |
| Aug 11, 2023 | -$ 0.09 | $ 0.95 | $ 0.9327 | |
| Aug 10, 2023 | -$ 0.09 | $ 1.02 | $ 0.92 | |
| May 15, 2023 | -$ 0.08 | $ 0.5552 | $ 0.6032 | |
| Mar 28, 2023 | -$ 0.09 | $ 0.49 | $ 0.4962 | |
| Mar 27, 2023 | -$ 0.09 | $ 0.5011 | $ 0.477 |
Cardiol Therapeutics released its most recent earnings reports in November 2026, August 2026, May 2026, March 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Cardiol Therapeutics missed analysts’ expectations during the last earnings period by
